tiprankstipranks

Esther Rajavelu Insider Profile

4 Followers
Esther Rajavelu, CFO at Fulcrum Therapeutics, holds ― shares in Fulcrum Therapeutics (Ticker: FULC), holds 379.27K shares in Spero Therapeutics (Ticker: SPRO). Most recently, Esther Rajavelu ― shares of Fulcrum Therapeutics on ― for an estimated value of ―.
tipranks
Esther Rajavelu

Esther Rajavelu
Fulcrum Therapeutics (FULC)
CFO

Not Ranked
Esther Rajavelu has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$436K
100.00%
0.00%
A breakdown of Esther Rajavelu's holdings

Insider Roles

Spero Therapeutics
(SPRO)
CFO & CBO
Fulcrum Therapeutics
(FULC)
CFO
Roles that Esther Rajavelu holds in companies

Most Profitable Insider Trade

Stock:
Spero Therapeutics
(SPRO)
Rating:Informative Sell
Date:Nov 12, 2024 - Today
Return:+12.10%
The most profitable trade made by Esther Rajavelu

Esther Rajavelu's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Fulcrum Therapeutics
CFO
Spero Therapeutics
Nov 12, 2024
CFO & CBO
Informative Sell
53.01K
$436.16K
List of latest transactions for each holding click on a transaction to see Esther Rajavelu's performance on stock

Esther Rajavelu insider profile FAQ

What is the percentage of profitable transactions made by Esther Rajavelu?
The percentage of profitable transactions made by Esther Rajavelu is ―.
    What is the average return per transaction made by Esther Rajavelu?
    The average return per transaction made by Esther Rajavelu is ―.
      What stocks does Esther Rajavelu hold?
      Esther Rajavelu holds: FULC, SPRO stocks.
        What was Esther Rajavelu’s latest transaction?
        Esther Rajavelu latest transaction was an Uninformative Buy of ―.
          What was Esther Rajavelu's most profitable transaction?
          Esther Rajavelu’s most profitable transaction was an Informative Sell of SPRO stock on November 12, 2024. The return on the trade was 12.10%.
            What is Esther Rajavelu's role in Fulcrum Therapeutics?
            Esther Rajavelu's role in Fulcrum Therapeutics is CFO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.